On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...
Astex Pharmaceuticals, Bristol Myers Squibb and Takeda have agreed to pool data to support work on an artificial intelligence model, joining AbbVie and Johnson & Johnson on the starry list of ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol Myers Squibb has said it hopes to be ready soon to file for approval of its multiple myeloma drug iberdomide after reporting positive results in a phase 3 trial. Full data from the ...
Bristol Myers Squibb announced an expansion of its direct-to-patient offerings, providing eligible US patients with steeply discounted prices for Eliquis (apixaban) and Sotyktu (deucravacitinib).
Laboratorios Farmacéuticos Rovi, which goes by Rovi, has inked a deal with Bristol Myers Squibb that gives the Spanish CDMO a production facility in Phoenix alongside a five-year manufacturing pact.
OG Box Office: Pawan Kalyan Already Enters Top 5 BMS Pre-Sales! ( Photo Credit – Instagram ) Must Read: Jolly LLB 3 Worldwide Box Office Day 2: Beats Son Of Sardaar 2 Overseas, Close To 50 Crores ...
OG Box Office Day 1: Pawan Kalyan Misses Occupancy Record! (Photo Credit – Instagram) The ticket sales of the film has surpassed the 200K mark from 6 AM to 5 PM on BMS. It would be interesting to see ...
Scott Saleska receives funding from National Science Foundation, NASA, and U.S. Department of Energy. Ghiwa Makke receives funding from National Science Foundation and U.S. Department of Energy. Chris ...
The fixes planned for Silent Hill 2 when running on a PS5 Pro have ended up in the hands of Konami, instead of Bloober Team. The developer said "publishing matters are handled by Konami" when asked ...
WASHINGTON, Oct 1 (Reuters) - U.S. manufacturing activity edged up in September, though new orders and employment were subdued as factories grappled with the fallout from President Donald Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results